13.17 USD
↗ 0.18 (1.39%)AT CLOSE (AS OF 07:31 PM EDT)
Bioventus Inc. Class A Common Stock
BVSNASDAQ • USD
Market: CLOSED
BVS is currently priced at $13.17. The technical outlook is "Sell" and the fundamental picture shows "Neutral". Key drivers include exceptional Return on Equity (25.1%) and a bullish Golden Cross on the moving averages. On the valuation side, BVS appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Sep 14, 2026.
Open?$13.00
High?$13.28
Low?$12.92
Prev. Close?$12.98
Volume?363.5K
Avg. Volume?720.4K
VWAP?$13.16
Rel. Volume?0.50x
Bid / Ask
Bid?$12.49 × 200
Ask?$14.00 × 100
Spread?$1.51
Midpoint?$13.25
Valuation & Ratios
Market Cap?886.6M
Shares Out?68.3M
Float?38.5M
Float %?56.8%
P/E Ratio?15.49
P/B Ratio?3.88
EPS?$0.84
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
Themes
Employees
950
Market Cap
886.6M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
Listed
2021-02-11
Address
4721 EMPEROR BOULEVARD, SUITE 100
DURHAM, NC 27703
Phone: (919) 474-6700
DURHAM, NC 27703
Phone: (919) 474-6700
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?38
Momentum?50
Short Sent.?44
Piotroski F-Score?5/9Mixed
Altman Z-Score?2.06Grey
Confidence?73%Moderate
Short InterestElevated
Short % of Float?6.71%Elevated
Short Interest?2.6M
Days to Cover?4.7
Free Float38.5M
Avg Daily Volume554.5K
Settlement Date2026-08-31
Financial Health
Current Ratio?1.69Adequate
Quick Ratio?1.17Adequate
Cash Ratio?0.19Low
Debt/Equity?1.09Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score94/100
P/E?15.5CHEAP▾
Peers100
S&P79
P/B?3.88FAIR▾
Peers100
S&P45
P/S?1.52CHEAP▾
Peers100
S&P78
P/FCF?9.4CHEAP▾
Peers100
S&P90
EV/EBITDA?10.5CHEAP▾
Peers100
S&P78
EV/Sales?1.90CHEAP▾
Peers100
S&P77
Returns & Efficiency
ROE?25.1%STRONG▾
Peers50
S&P74
ROA?8.5%STRONG▾
Peers50
S&P68
Cash Flow & Enterprise
FCF?$94.3M
Enterprise Value?$1.1B
Fundamentals ratios updated end of day